These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34396420)

  • 1. Type I Interferon Signature in Chilblains Following SARS-CoV-2 mRNA Vaccine: A Case Report.
    Souaid K; Oulès B; Sohier P; Deschamps L; Aractingi S; Dupin N
    Acta Derm Venereol; 2021 Nov; 101(11):adv00589. PubMed ID: 34396420
    [No Abstract]   [Full Text] [Related]  

  • 2. BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2.
    Piccolo V; Bassi A; Argenziano G; Mazzatenta C; Cutrone M; Neri I; Grimalt R; Russo T
    J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):e493-e494. PubMed ID: 33914966
    [No Abstract]   [Full Text] [Related]  

  • 3. Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that 'COVID toes' are due to the immune reaction to SARS-CoV-2.
    Lesort C; Kanitakis J; Donzier L; Jullien D
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e630-e632. PubMed ID: 34131969
    [No Abstract]   [Full Text] [Related]  

  • 4. Chilblains and COVID-19-An Update on the Complexities of Interpreting Antibody Test Results, the Role of Interferon α, and COVID-19 Vaccines.
    Sun Q; Freeman EE
    JAMA Dermatol; 2022 Feb; 158(2):217-218. PubMed ID: 34935876
    [No Abstract]   [Full Text] [Related]  

  • 5. Chilblains and COVID-19-An Update on the Complexities of Interpreting Antibody Test Results, the Role of Interferon α, and COVID-19 Vaccines-Reply.
    McCleskey PE; Lieberman A; Herrinton LJ
    JAMA Dermatol; 2022 Feb; 158(2):218-219. PubMed ID: 34935853
    [No Abstract]   [Full Text] [Related]  

  • 6. A Case of Chilblains-like Lesions Post SARS-CoV-2 Vaccine?
    Meara AS; Silkowski M; Quin K; Jarjour W
    J Rheumatol; 2021 Nov; 48(11):1754. PubMed ID: 34210829
    [No Abstract]   [Full Text] [Related]  

  • 7. Chilblain lesions after COVID-19 mRNA vaccine.
    Pileri A; Guglielmo A; Raone B; Patrizi A
    Br J Dermatol; 2021 Jul; 185(1):e3. PubMed ID: 33904168
    [No Abstract]   [Full Text] [Related]  

  • 8. Impaired type I interferon response in SARS-CoV-2 infection: looking through the cutaneous window.
    Bessis D
    Br J Dermatol; 2021 Jan; 184(1):11-12. PubMed ID: 33249567
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 pandemic-associated chilblains: more links for SARS-CoV-2 and less evidence for high interferon type I systemic response.
    Bessis D; Trouillet-Assant S; Secco LP; Bardin N; Blanc B; Blatière V; Chable-Bessia C; Delfour C; Girard C; Richard JC; Gros N; Le Moing V; Molinari N; Pallure V; Pisoni A; Raison-Peyron N; Reynaud E; Schwob É; Pescarmona R; Samaran Q; Willems M; Vincent T; Sofonea MT; Belot A; Tuaillon É
    Br J Dermatol; 2022 Dec; 187(6):1032-1035. PubMed ID: 35971922
    [No Abstract]   [Full Text] [Related]  

  • 10. Chilblains observed during the COVID-19 pandemic cannot be distinguished from classic, cold-related chilblains.
    De Greef A; Choteau M; Herman A; Bouzin C; Marot L; Dachelet C; Lelotte J; Hoton D; Dumoutier L; Baeck M
    Eur J Dermatol; 2022 May; 32(3):377-383. PubMed ID: 36065533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post SARS-CoV-2 Vaccine Chilblains-like Lesions.
    Mungmunpuntipantip R; Wiwanitkit V
    J Rheumatol; 2022 Jul; 49(7):859. PubMed ID: 35428717
    [No Abstract]   [Full Text] [Related]  

  • 12. Pandemic chilblains: Are they SARS-CoV-2-related or not?
    De Greef A; Coulie PG; Baeck M
    Clin Immunol; 2022 Apr; 237():108984. PubMed ID: 35338000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chilblains during lockdown are associated with household exposure to SARS-CoV-2: a multicentre case-control study.
    Poizeau F; Oger E; Barbarot S; Le Corre Y; Samimi M; Brenaut E; Aubert H; Chambrelan E; Droitcourt C; Gissot V; Heslan C; Laurent C; Martin L; Misery L; Tattevin P; Toubel A; Thibault V; Dupuy A
    Clin Microbiol Infect; 2022 Feb; 28(2):285-291. PubMed ID: 34619397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pernio-like skin lesions after the second dose of Pfizer-BioNTech COVID-19 vaccine.
    Cameli N; Silvestri M; Mariano M; Nisticò SP; Cristaudo A
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e725-e727. PubMed ID: 34236735
    [No Abstract]   [Full Text] [Related]  

  • 15. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases.
    Colmenero I; Santonja C; Alonso-Riaño M; Noguera-Morel L; Hernández-Martín A; Andina D; Wiesner T; Rodríguez-Peralto JL; Requena L; Torrelo A
    Br J Dermatol; 2020 Oct; 183(4):729-737. PubMed ID: 32562567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitis.
    Maranini B; Ciancio G; Cultrera R; Govoni M
    Reumatismo; 2021 Nov; 73(3):. PubMed ID: 34814659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature.
    Paparella R; Tarani L; Properzi E; Costantino F; Saburri C; Lucibello R; Richetta A; Spalice A; Leonardi L
    Ital J Pediatr; 2022 Jun; 48(1):93. PubMed ID: 35698236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chilblains After SARS-CoV-2 Vaccination: Coincidence or Real Association?
    Karamanakos A; Evangelatos G; Pappa M; Fragiadaki K; Fanouriakis A; Fragoulis GE
    J Rheumatol; 2022 Nov; 49(11):1295-1296. PubMed ID: 35914789
    [No Abstract]   [Full Text] [Related]  

  • 19. Pernio after COVID-19 vaccination.
    Lopez S; Vakharia P; Vandergriff T; Freeman EE; Vasquez R
    Br J Dermatol; 2021 Aug; 185(2):445-447. PubMed ID: 33893637
    [No Abstract]   [Full Text] [Related]  

  • 20. Perniosis-like lesions after vaccination with mRNA against COVID-19.
    Pérez-López I; Gil-Villalba A; Ruiz-Villaverde R
    Med Clin (Barc); 2022 Feb; 158(4):189-190. PubMed ID: 34229882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.